Idexx Laboratories Europe, the Middle East and Africa — Total Revenue increased by 1.1% to $257.05M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.7%, from $204.55M to $257.05M. Over 4 years (FY 2021 to FY 2025), Europe, the Middle East and Africa — Total Revenue shows an upward trend with a 8.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful market expansion, higher adoption of diagnostic equipment, or increased utilization of reference lab services in the region, while a decrease may indicate competitive pressure, economic headwinds, or reduced veterinary clinic activity.
This metric represents the total consolidated revenue generated from the sale of diagnostic products, equipment, and vet...
Comparable to regional revenue reporting for other multinational healthcare or medical device companies, often benchmarked against regional GDP growth and veterinary market spending trends.
idxx_segment_europe_the_middle_east_and_africa_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $171.55M | $167.96M | $171.19M | $173.81M | $161.99M | $152.24M | $159.00M | $176.01M | $178.67M | $177.85M | $183.66M | $199.83M | $200.69M | $198.61M | $207.61M | $204.55M | $233.27M | $245.06M | $254.37M | $257.05M |
| QoQ Change | — | -2.1% | +1.9% | +1.5% | -6.8% | -6.0% | +4.4% | +10.7% | +1.5% | -0.5% | +3.3% | +8.8% | +0.4% | -1.0% | +4.5% | -1.5% | +14.0% | +5.1% | +3.8% | +1.1% |
| YoY Change | — | — | — | — | -5.6% | -9.4% | -7.1% | +1.3% | +10.3% | +16.8% | +15.5% | +13.5% | +12.3% | +11.7% | +13.0% | +2.4% | +16.2% | +23.4% | +22.5% | +25.7% |